Straits Times Index
3,315.21 +7.31 (+0.22%) Nikkei
39,030.06 +412.96 (+1.07%) Hang Seng
18,933.99 -261.61 (-1.36%) FTSE 100
8,370.33 -46.12 (-0.55%) Bitcoin USD
69,313.92 -590.48 (-0.84%) CMC Crypto 200
1,510.01 -16.41 (-1.07%)
Know Labs, Inc. (KNW)
After hours:
| Previous close | 0.6660 |
| Open | 0.6600 |
| Bid | 0.6130 x 800 |
| Ask | 0.6360 x 800 |
| Day's range | 0.6051 - 0.6600 |
| 52-week range | 0.2300 - 1.4800 |
| Volume | |
| Avg. volume | 117,446 |
| Market cap | 56.951M |
| Beta (5Y monthly) | 1.54 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Know Labs Appoints Chris Somogyi as President, International
SEATTLE, May 16, 2024--Know Labs, Inc. (NYSE American: KNW), an emerging leader in non-invasive medical diagnostic technology, today announced the appointment of Chris Somogyi as President, International. With over 40 years of experience in commercializing innovation across related industries, Somogyi brings a wealth of expertise to lead the Company's "Skunkworks" Program and global patent licensing efforts.
- Business Wire
Know Labs, Inc. Reports Second Quarter FY 2024 Results
SEATTLE, May 15, 2024--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the second quarter of the fiscal year 2024 ended March 31, 2024.
- Business Wire
Know Labs to Present Clinical Research at the 2024 American Association of Clinical Endocrinology Annual Meeting
SEATTLE, May 09, 2024--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been selected for an oral abstract presentation at the American Association of Clinical Endocrinology (AACE) Annual Meeting in New Orleans, Louisiana on May 9, 2024 from 11:15 a.m. – 11:30 a.m. CDT.
